China Sees Flurry Of Activity On Avastin

Innovent’s Biosimilar Bevacizumab Approved As Bio-Thera And Henlius Advance

 
• By David Wallace
  
Eye_China_Flag
China has seen an approval for one bevacizumab biosimilar, with others in the pipeline • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products